Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
1998-4-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
338
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1312; author reply 1312-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9565491-Carrier State,
pubmed-meshheading:9565491-DNA, Viral,
pubmed-meshheading:9565491-HIV Infections,
pubmed-meshheading:9565491-Hepatitis B,
pubmed-meshheading:9565491-Hepatitis B Antibodies,
pubmed-meshheading:9565491-Hepatitis B Surface Antigens,
pubmed-meshheading:9565491-Hepatitis B virus,
pubmed-meshheading:9565491-Humans
|
pubmed:year |
1998
|
pubmed:articleTitle |
Hepatitis B virus infection.
|
pubmed:publicationType |
Letter,
Comment
|